The Beneficial Effect of Adenophorae Radix on DSS-induced Colitis in Mice

  • Jung, Ji-Wook (Department of Herbal Medicinal Pharmacology, College of Herbal Bio-industry, Daegu Haany University) ;
  • Oh, Sa-Rang (College of Pharmacy, Keimyung University) ;
  • Ahn, Eun-Mi (Department of Herbal Foodceutical Science, College of Health and Welfare, Daegu Haany University) ;
  • Yang, Eun-Ju (Department of Clinical Laboratory Science, Daegu Haany University) ;
  • Kim, Su-Jin (Department of Cosmeceutical Science, Daegu Hanny University)
  • Received : 2013.03.04
  • Accepted : 2013.07.03
  • Published : 2013.09.30

Abstract

Ulcerative colitis (UC) is an inflammatory bowel disease, which is a chronic gastrointestinal disorder. Adenophorae Radix (AR) has been used as a traditional medicine for various diseases including strengthening cardiac function, allaying a fever, and easing pain and cough. However, the regulatory effects of AR in intestinal inflammation are not yet understood. This study attempted to determine the effect of AR in dextran sulfate sodium (DSS) - induced colitis in mice. The colitis mice were induced by drinking water containing 5% DSS for 7 days. The results showed that mice treated with DSS showed remarkable clinical signs, including weight loss, and reduced colon length. Administration of AR attenuated weight loss, colon shortening and inhibited the levels of interleukin (IL) - 6 in DSS - treated colon tissues. These results provide experimental evidence that AR might be a useful therapeutic medicine for patients with UC.

Keywords

References

  1. Ardizzone S, Bianchi PG. Biologic therapy for inflammatory bowel disease. Drugs 2005. 65: 2253-2286. https://doi.org/10.2165/00003495-200565160-00002
  2. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003. 3: 521-533. https://doi.org/10.1038/nri1132
  3. Camuesco D, Galvez J, Nieto A, Comalada M, Rodriguez-Cabezas ME, Concha A, Xaus J, Zarzuelo A. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr. 2005. 135: 687-694.
  4. Copper HS, Murthy SNS, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993. 69: 238-249.
  5. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998. 115: 182-205. https://doi.org/10.1016/S0016-5085(98)70381-6
  6. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and Pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002. 15: 79-94. https://doi.org/10.1128/CMR.15.1.79-94.2002
  7. Ishiguro K, Ando T, Maeda O, Hasegawa M, Kadomatsu K, Ohmiya N, Niwa Y, Xavier R, Goto H. Paeonolattenuates TNBS-induced colitis by inhibiting NF-${\kappa}B$ and STAT1 transactivation. Toxicol Appl Pharmacol. 2006. 217: 35-42. https://doi.org/10.1016/j.taap.2006.07.002
  8. Kim SJ, Kim YG, Kim DS, Jeon YD, Kim MC, Kim HL, Kim SY, Jang HJ, Lee BC, Hong SH, Um JY. Oldenlandia diffusa Ameliorates Dextran Sulfate Sodium-Induced Colitis Through Inhibition of NF-kappa B Activation. Am J Chin Med. 2011. 39: 957-969. https://doi.org/10.1142/S0192415X11009330
  9. Kim SJ, Kim KW, Kim DS, Kim MC, Jeon YD, Kim SG, Jung HJ, Jang HJ, Lee BC, Chung WS, Hong SH, Chung SH, Um JY. The Protective Effect of Cassia obtusifolia on DSS-Induced Colitis. Am J Chin Med. 2011. 39: 565-577. https://doi.org/10.1142/S0192415X11009032
  10. Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R, Xia B, Kuipers EJ, van der Woude J. Disease-related expression of the IL-6/STAT3/SOCS3 signaling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis. Gut. 2010. 59: 227-235. https://doi.org/10.1136/gut.2009.184176
  11. Lin TY, Liu YC, Jheng JR, Tsai HP, Jan JT, Wong WR, Horng JT. Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities. Am J Chin Med. 2009. 37: 143-158. https://doi.org/10.1142/S0192415X09006734
  12. MacDonald TT, Murch SH. Aetiology and pathogenesis of chronic inflammatory bowel disease. Baillieres Clin. Gastroenterol. 1994. 8: 1-34.
  13. Murthy SN, Cooper HS, Shim H, Shah RS, Ibarahim SA, Sedergran DJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci. 1993. 38: 1722-1734. https://doi.org/10.1007/BF01303184
  14. Ramakers JD, Verstege MI, Thuijls G, Te Velde AA, Mensink RP, Plat J. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis. J Clin Immunol. 2007. 27: 275-283. https://doi.org/10.1007/s10875-007-9074-2
  15. Roh SS, Kim SH, Lee YC, Seo YB. Effects of radix adenophorae and cyclosporine A on an OVA-induced murine model of asthma by suppressing to T cells activity, eosinophilia, and bronchial hyperresponsiveness. Mediators Inflamm. 2008. 2008: 781425.
  16. Rufo PA, Bousvaros A. Current therapy of inflammatory bowel disease in children. Paediatr Drugs. 2006. 8: 279-302. https://doi.org/10.2165/00148581-200608050-00002
  17. Sato K, Ohkura S, Kitahara Y, Ohama T, Hori M, Sato M, Kobayashi S, Sasaki Y, Hayashi T, Nasu T, Ozaki H. Involvement of CPI-17 downregula in the dysmotility of the colon from dextran sodium sulfate-induced experimental colitis in a mouse model. Neurogastroenterol Motil. 2007. 19: 504-514. https://doi.org/10.1111/j.1365-2982.2007.00911.x
  18. Sandborn, WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology. 2002. 122: 1592-1608. https://doi.org/10.1053/gast.2002.33426
  19. Talhouk RS, Karam C, Fostok S, El-Jouni W, Barbour EK. Anti-inflammatory bioactivities in plant extracts. J Med Food. 2007. 10: 1-10. https://doi.org/10.1089/jmf.2005.055
  20. Yang SK. Current status and clinical characteristics of inflammatory bowel disease in Korea. Korean J Gastroenterol. 2002. 40: 1-14.
  21. Zheng P, Niu FL, Liu WZ, Shi Y, Lu LG. Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodiuminduced colitisofrats. World J Gastroenterol. 2005. 11: 4912-4915.